Related Experiment Videos
Pharmacogenetics of psychoactive drugs
1Institute of Psychiatric Research, Indiana University Medical Center, Indianapolis 46223.
Journal of Psychiatric Research
|January 1, 1987
Summary
Genetic factors significantly influence how individuals respond to psychoactive drugs, impacting antidepressant metabolism and substance abuse disorders. Twin studies reveal heritable variations in responses to specific drug challenges.
Area of Science:
- Pharmacogenetics
- Neuroscience
- Psychiatry
Background:
- Individual responses to psychoactive medications vary significantly.
- Genetic factors are known to influence drug metabolism and efficacy.
- Substance abuse disorders and affective disorders may involve complex genetic underpinnings.
Purpose of the Study:
- To investigate the role of genetic variation in psychoactive drug response.
- To explore familial influences on responses to specific neurochemical agents.
- To examine potential neurochemical differences in bipolar disorder.
Main Methods:
- Analysis of heritable differences in antidepressant metabolism.
- Pharmacologic challenge studies using volunteer twins with agents like arecoline and amphetamine.
- Comparison of arecoline responses in euthymic bipolar patients versus control groups.
Main Results:
- Heritable differences in antidepressant metabolism are clinically relevant.
- Familial variations in responses to cholinergic (arecoline) and monoaminergic (amphetamine) agonists were observed.
- Arecoline response patterns differentiated bipolar patients from controls, suggesting muscarinic supersensitivity.
Conclusions:
- Genetic variability plays a crucial role in psychoactive drug response.
- Pharmacogenetic approaches are vital for understanding substance abuse and affective disorders.
- Further research using genetically characterized animal models can elucidate neurochemical mechanisms.